ASCO Value Framework Could Inform Clinical Pathways, Payers Say
Executive Summary
Aetna’s Kolodziej and Anthem’s Malin discuss how the American Society for Clinical Oncology’s framework for valuing cancer drugs might influence payer decision-making and drug access.